Two Sigma Investments’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108M Buy
2,251,525
+1,570,277
+231% +$68.8M 0.09% 262
2025
Q4
$26.3M Sell
681,248
-503,063
-42% -$19.2M 0.04% 592
2025
Q3
$41.8M Buy
1,184,311
+1,130,209
+2,089% +$40.9M 0.06% 373
2025
Q2
$1.95M Sell
54,102
-1,558,907
-97% -$51.6M ﹤0.01% 1853
2025
Q1
$50.2M Sell
1,613,009
-807,394
-33% -$25.6M 0.11% 235
2024
Q4
$61.7M Sell
2,420,403
-8,933
-0.4% -$237K 0.14% 181
2024
Q3
$68.7M Buy
2,429,336
+371,796
+18% +$10.3M 0.16% 162
2024
Q2
$54.3M Buy
2,057,540
+753,881
+58% +$20.9M 0.13% 194
2024
Q1
$39.6M Sell
1,303,659
-807,609
-38% -$23.8M 0.1% 271
2023
Q4
$59.3M Sell
2,111,268
-95,447
-4% -$2.62M 0.14% 189
2023
Q3
$59.9M Buy
2,206,715
+1,075,019
+95% +$31.9M 0.17% 173
2023
Q2
$34.8M Buy
1,131,696
+957,412
+549% +$32.4M 0.09% 282
2023
Q1
$6.28M Sell
174,284
-265,825
-60% -$9.86M 0.02% 801
2022
Q4
$17.4M Sell
440,109
-351,231
-44% -$14.7M 0.06% 391
2022
Q3
$31.8M Buy
791,340
+320,393
+68% +$13.7M 0.11% 237
2022
Q2
$19.8M Buy
470,947
+283,920
+152% +$11.6M 0.07% 329
2022
Q1
$7.29M Buy
187,027
+33,552
+22% +$1.32M 0.02% 741
2021
Q4
$6.12M Buy
+153,475
New +$5.96M 0.02% 1078

Other funds holding RPRX